An essential role for Cmtr2 in mammalian embryonic development.
2’-O-methylation
CMTR2
ISGs
cap2
endothelial cells
innate immunity
interferon response
p53 signaling pathway
ribose methylation
vascular development
Journal
Developmental biology
ISSN: 1095-564X
Titre abrégé: Dev Biol
Pays: United States
ID NLM: 0372762
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
14
07
2023
revised:
26
07
2024
accepted:
30
07
2024
medline:
3
8
2024
pubmed:
3
8
2024
entrez:
2
8
2024
Statut:
aheadofprint
Résumé
CMTR2 is an mRNA cap methyltransferase with poorly understood physiological functions. It catalyzes 2'-O-ribose methylation of the second transcribed nucleotide of mRNAs, potentially serving to mark RNAs as "self" to evade the cellular innate immune response. Here we analyze the consequences of Cmtr2 deficiency in mice. We discover that constitutive deletion of Cmtr2 results in mouse embryos that die during mid-gestation, exhibiting defects in embryo size, placental malformation and yolk sac vascularization. Endothelial cell deletion of Cmtr2 in mice results in vascular and hematopoietic defects, and perinatal lethality. Detailed characterization of the constitutive Cmtr2 KO phenotype shows an activation of the p53 pathway and decreased proliferation, but no evidence of interferon pathway activation. In summary, our study reveals the essential roles of Cmtr2 in mammalian cells beyond its immunoregulatory function.
Identifiants
pubmed: 39094818
pii: S0012-1606(24)00199-4
doi: 10.1016/j.ydbio.2024.07.019
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflicts of interest with the contents of this article. M.M. consults for and holds equity in Bayer, Delve Bio, and Isabl, receives research funding from Bayer and Janssen, and receives patent royalties from Bayer and Labcorp, all outside the scope of the current work.